Deferiprone for transfusional iron overload and its roles in developing countries
Introduction: Variations in chelation efficacy and adverse events in particular neutropenia and agranulocytosis relegate deferiprone (DFP) to a second-line therapy in iron overload patients in whom iron chelation with deferoxamine (DFO) is inadequate. With a major economical constraint, many patient...
Saved in:
Main Authors: | Vip Viprakasit, Sarayuth Rodmai, Somdet Srichairatanakool |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84896702474&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/53835 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Deferiprone for transfusional iron overload and its roles in developing countries
by: Vip Viprakasit, et al.
Published: (2018) -
Deferiprone for transfusional iron overload and its roles in developing countries
by: Vip Viprakasit, et al.
Published: (2018) -
Deferiprone and efonidipine mitigated iron-overload induced neurotoxicity in wild-type and thalassemic mice
by: Jirapas Sripetchwandee, et al.
Published: (2020) -
Iron distribution and histopathological study of the effects of deferoxamine and deferiprone in the kidneys of iron overloaded β-thalassemic mice
by: Paranee Yatmark, et al.
Published: (2018) -
Iron distribution and histopathological characterization of the liver and heart of β-thalassemic mice with parenteral iron overload: Effects of deferoxamine and deferiprone
by: Paranee Yatmark, et al.
Published: (2018)